IBDEI0IK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8351,1,4,0)
 ;;=4^B37.42
 ;;^UTILITY(U,$J,358.3,8351,2)
 ;;=^5000617
 ;;^UTILITY(U,$J,358.3,8352,0)
 ;;=A59.03^^39^398^110
 ;;^UTILITY(U,$J,358.3,8352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8352,1,3,0)
 ;;=3^Trichomonal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,8352,1,4,0)
 ;;=4^A59.03
 ;;^UTILITY(U,$J,358.3,8352,2)
 ;;=^5000349
 ;;^UTILITY(U,$J,358.3,8353,0)
 ;;=E87.6^^39^398^63
 ;;^UTILITY(U,$J,358.3,8353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8353,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,8353,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,8353,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,8354,0)
 ;;=F52.0^^39^398^62
 ;;^UTILITY(U,$J,358.3,8354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8354,1,3,0)
 ;;=3^Hypoactive Sexual Desire Disorder
 ;;^UTILITY(U,$J,358.3,8354,1,4,0)
 ;;=4^F52.0
 ;;^UTILITY(U,$J,358.3,8354,2)
 ;;=^5003618
 ;;^UTILITY(U,$J,358.3,8355,0)
 ;;=F52.22^^39^398^105
 ;;^UTILITY(U,$J,358.3,8355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8355,1,3,0)
 ;;=3^Sexual Arousal Disorder,Female
 ;;^UTILITY(U,$J,358.3,8355,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,8355,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,8356,0)
 ;;=F52.8^^39^398^106
 ;;^UTILITY(U,$J,358.3,8356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8356,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,8356,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,8356,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,8357,0)
 ;;=F52.21^^39^398^35
 ;;^UTILITY(U,$J,358.3,8357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8357,1,3,0)
 ;;=3^Erectile Disorder,Male (Psychogenic)
 ;;^UTILITY(U,$J,358.3,8357,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,8357,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,8358,0)
 ;;=I12.9^^39^398^61
 ;;^UTILITY(U,$J,358.3,8358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8358,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,8358,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,8358,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,8359,0)
 ;;=N04.9^^39^398^78
 ;;^UTILITY(U,$J,358.3,8359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8359,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,8359,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,8359,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,8360,0)
 ;;=N02.9^^39^398^55
 ;;^UTILITY(U,$J,358.3,8360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8360,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
 ;;^UTILITY(U,$J,358.3,8360,1,4,0)
 ;;=4^N02.9
 ;;^UTILITY(U,$J,358.3,8360,2)
 ;;=^5015520
 ;;^UTILITY(U,$J,358.3,8361,0)
 ;;=N06.9^^39^398^95
 ;;^UTILITY(U,$J,358.3,8361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8361,1,3,0)
 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,8361,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,8361,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,8362,0)
 ;;=N05.9^^39^398^75
 ;;^UTILITY(U,$J,358.3,8362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8362,1,3,0)
 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,8362,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,8362,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,8363,0)
 ;;=N07.9^^39^398^77
 ;;^UTILITY(U,$J,358.3,8363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8363,1,3,0)
 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
 ;;^UTILITY(U,$J,358.3,8363,1,4,0)
 ;;=4^N07.9
